Morbid obesity. Morbid obesity
Conditions
Interventions
Intervention 1: Intervention: Doxapram. Intervention 2: control: Normal Salin.
Treatment - Drugs
Placebo
Intervention: Doxapram
control: Normal Salin
Sponsors
Shahid Modarrs Hospital, Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients with ASA Class I, II; body mass index over 45; patients with a history of OSA; smokers; the patient consent to participate in the plan. Exclusion criteria: use of drugs; cardiac diseases; the cause of longer than 3 hours surgery or surgical complications occur.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The timing of the return of spontaneous breathing after the injection reverse dose in doxapram group and the control group. Timepoint: since revers dose of muscular blocker until spontaneous respiration. Method of measurement: With the clock. | — |
Secondary
| Measure | Time frame |
|---|---|
| Train-of-four monitor to determine the recovery time after the reverse dose doxapram group and the control group. Timepoint: Since reversal dose of muscular blocker until return muscular blockage. Method of measurement: With the train-of-four monitor.;End Tidal Co2 determine the reverse dose doxapram group and the control group in 5 minutes. Timepoint: Every 5 minute. Method of measurement: Capnograhpy. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNilofar Massoudi
Shahid beheshti University of Medical Sciences
Outcome results
None listed